A novel ALS (amyotrophic lateral sclerosis) study has pooled data from multiple sites to effectively visualize neuroinflammation, which is key to developing drugs to treat the disease. Pooling data acquired from different ...
Dec 1, 2020
0
9
The first Canadian guideline for the care and management of patients with amyotrophic lateral sclerosis (ALS)—Lou Gehrig's disease—recommends a patient-focused approach, with attention to holistic and emotional aspects ...
Nov 16, 2020
0
4
A tiny device the size of a small paperclip has been shown to help patients with upper limb paralysis to text, email and even shop online in the first human trial.
Oct 28, 2020
0
2
An experimental medication that was recently shown to slow the progression of the neurodegenerative disease amyotrophic lateral sclerosis (ALS), or Lou Gehrig's disease, has now demonstrated the potential to also prolong ...
Oct 16, 2020
0
104
An experimental medication slows the progression of the neurodegenerative disease called Amyotrophic lateral sclerosis (ALS), or Lou Gehrig's disease, according to recently released results from a clinical trial run by investigators ...
Sep 2, 2020
0
51
The human genome contains over 4.5 million sequences of DNA called "transposable elements," virus-like entities that "jump" around and help regulate gene expression. They do this by binding transcription factors, which are ...
Aug 31, 2020
0
183
Researchers demonstrated the success of a fully implantable wireless medical device called a stentrode brain-computer interface designed to improve functional independence in patients with severe paralysis. The abstract was ...
Aug 6, 2020
0
3
Stanford researchers have been working for years to advance a technology that could one day help people with paralysis regain use of their limbs, and enable amputees to use their thoughts to control prostheses and interact ...
Aug 4, 2020
0
284
A protein linked to amyotrophic lateral sclerosis (ALS), a progressive neurological disease that causes muscle weakness, may be a key to treating fibrotic disease of the kidneys and other organs, researchers at Vanderbilt ...
Jul 31, 2020
1
82
A study published in the New England Journal of Medicine has shown the safety and tolerability of the new investigational drug tofersen, which has the potential to reduce the levels of a toxic cell protein in people living ...
Jul 13, 2020
0
8
